Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines Immunotherapy
Researchers from Monash University detail findings in cancer vaccines immunotherapy
August 26th, 2008
A new study, 'Targeted therapies to improve tumor immunotherapy,' is now available. According to a study from Melbourne, Australia, "Durable tumor regression and potential cures of metastatic solid cancers can be achieved by a variety of cellular immunotherapy strategies, including cytokine therapy, dendritic cell-based vaccines, and immune-activating antibodies, when used in so-called immune-sensitive cancers such as melanoma and renal cell carcinoma. However, these immunotherapy strategies have very low tumor response rates, usually in the order of 5% to 10% of treated patients." "We propose that the antitumor activity of adequately stimulated tumor antigen-specific T...
Source: Cancer Weekly (2008-08-26)
|
